USPTO serial 98873501
MIMIX
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- PINO, DOMINIC ROBERT
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with MIMIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kevin Oliver
Kevin Oliver Revvity, Inc.77 4th AvenueWaltham, MA 02451United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological preparations for laboratory, biopharmaceutical processing, and research purposes, for use as reference standards in science; Biological preparations for cancer research; Biological preparations for quality control of laboratory research; Cell line-derived nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, for use as reference standards for research purpose; Samples made of nucleic acids for use in biochemical or biological laboratory analysis for research purposes; Samples made of formalin and nucleic acids for use in a biochemical or biological laboratory analysis for research purposes; Samples made of formalin and cells for use in a biochemical or biological laboratory analysis for research purposes; Cell line-derived products in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, for scientific and research purposes, including for clinical investigations and for use in product testing; Reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for research purposes, namely, used for next generation sequencing, droplet-digital, Real-Time Polymerase Chain Reaction (PCR) or Sanger sequencing | ACTIVE | — |
| 005 | cell line-derived reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used in clinical medical samples; Reference standard substances in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for clinical tests for medical purposes; medical reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for next generation sequencing, droplet-digital, Real-Time Polymerase Chain Reaction (PCR) or Sanger sequencing; medical reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for detecting chromosomal abnormalities; medical reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for analysing biological samples | ACTIVE | — |
| 040 | Custom manufacture of cell line-delivered products in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, for medical and commercial applications; Custom manufacture of reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Revvity Health Sciences, Inc.
- Other trademarks owned by Revvity Health Sciences, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Similar marks named MIMIX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 10, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 10, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 10, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 10, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 10, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 16, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 16, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 10, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 18, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 7, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 26, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 26, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 26, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 11, 2025 | ALIE | ASSIGNED TO LIE | — |
| May 27, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 27, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 27, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 19, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 26, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 26, 2024 | NWAP | NEW APPLICATION ENTERED | — |